Literature DB >> 24167397

Hb H Interference on Measurement Of HbA1c With Ion-Exchange HPLC.

Mehmet Agilli1, Halil Yaman, Fevzi Nuri Aydinl, Tuncer Cayci, Irfan Sener.   

Abstract

In this article, an interference caused by hemoglobin H (Hb H), during the measurement of hemoglobin A1c (HbA1c) with ion exchange high pressure liquid chromatography (HPLC) method, was presented in blood sample of a 20-year-old male patient. HbA1c measurement was performed with Agilent 1200 HPLC system using a commercial Recipe HbA1c ion-exchange column. Hemoglobin electrophoresis was performed with Interlab G26 agarose electrophoresis automated compact system. HbA1c level was 18.2% and HbA0 level was 81.5% with ion-exchange HPLC method. Patient's fasting serum glucose was assessed before HbA1c measurement and the result was 165 mg/dL (9.16 mmol/L). On the other hand, the result of HbA0 was 87.9%, Hb H was 10.8% and Hb A2 was 1.3% with electrophoresis. Whole blood test values were within reference ranges except MCV. MCV value was 79.6 fL. It is important to keep in mind that HbA1c level might be considered falsely high with ion-exchange HPLC method because of Hb H containing sample.

Entities:  

Keywords:  Hemoglobin A1c; Hemoglobin H; High Pressure Liquid Chromatography.

Year:  2013        PMID: 24167397      PMCID: PMC3804497          DOI: 10.5455/aim.2013.21.216-218

Source DB:  PubMed          Journal:  Acta Inform Med        ISSN: 0353-8109


INTRODUCTION

According to International Federation of Clinical Chemistry (IFCC), hemoglobin A1c (HbA1c) is defined as hemoglobin that is irreversibly glycated at one or both N-terminal valines of the beta chains (1). HbA1c has been the most widely used and accepted test for diagnosing and monitoring the glycaemic control in individuals with diabetes (2). Several methods are used to determine HbA1c levels; based on chemical, structural and charge characteristics of the molecule; such as electrophoresis, isoelectric focusing, high pressure liquid chromatography (HPLC), affinity chromatography, immune measurements. Because of the variety of measurement methods and the factors causing interference; standardization has not been achieved yet (3). Hemoglobinopathy is one of the factors that causes interference. Cayci et al. has shown that increased Hb F levels, which is the major hemoglobin of fetal life, cause falsely high HbA1c results (4) It was reported that Hb F, Hb S, Hb C and Hb D also caused false HbA1c results when used HPLC method (5). National Glycohemoglobin Standardization Program (NGSP) was established by American Assossiation for Clinical Chemistry (AACC) to study for standardization of HbA1c measurement in 1996. NGSP has published several factors that cause interference in HbA1c measurement (6). Alpha thalassemia is a common genetic disorder that is characterized by deficient or absent synthesis of alpha globin chains of the hemoglobin molecule. The α-thalassemias usually result from deletions involving the α-globin genes, less commonly they are due to point (nondeletion) mutations. The incidence of alpha thalassemia is about 3 per cent in the Çukurova region at Southern Turkey (7). There can be differences between several HPLC methods. Little et al. reported that, higher HbA1c results were obtained with affinity chromatography method than other HPLC methods in the presence of Hb E (8). This finding was supported with another study (9). Moiz et al. thought affinity chromatography was superior than other HPLC methods for measurement of HbA1c (10). However Tiran et al. compared boronate affinity chromatography method and ion-exchange HPLC method for measurement of HbA1c and found good correlation with each other and acceptable coefficient of variation (CV%) values for each method of HbA1c assay performance (11). In our laboratory, HbA1c measurement performed with ion-exchange chromatography method using the Agilent 1200 instrument (Agilent technologies, USA) and HbA1c commercially kit was Recipe HbA1c (Recipe Chemicals – Instruments GmbH, Munich, Germany). This HPLC technique was certified by NGSP. Hemoglobin electrophoresis was performed with Interlab G26 agarose electrophoresis automated compact system (Via Rina Monti, Rome, Italy). In this article, we wanted to draw attention the interference caused by Hb H, a variant hemoglobin, during the measurement of HbA1c with ionexchange HPLC method in a sample from a 20-year-old patient whose fasting plasma glucose level was 165 mg/dL (9.16 mmol/L).

CASE REPORT

HbA1c assay was performed for a 20-year-old patient follow-up because of his elevated fasting plasma glucose level (165 mg/dL; 9.16 mmol/L). In our laboratory, we use HPLC device equipped with UV-1000 visible detector (Shimadzu Class-VP, Kyoto, Japan) and Recipe HbA1c assay kit (Recipe Chemicals– Instruments GmbH, Munich, Germany) for HbA1c measurement. The standart and control materials were appropriate for IFCC standards. Intraassay and interassay coefficient of variations (CVs) were 1.6% and 2.4%, respectively. Hemoglobin electrophoresis was performed with Interlab G26 (Via Rina Monti, Rome, Italy) device with Interlab SRE604K (Via Rina Monti, Rome, Italy) assay kit. HbA1c and HbA0 were found 18.2% and 81.5%, respectively (Figure 1).
Figure 1.

Chromatogram of HbA1c with HPLC. HbA1c and Hb H peaks were thought to be overlapped.

The very high level of HbA1c was disputable and we decided to do hemoglobin electrophoresis. Consequently, we established that Hb A0 result was 87.9%; Hb H result was 10.8% and Hb A2 result was 1.3% (Figure 2).
Figure 2.

Electropherogram of patient’s blood specimen.

DISCUSSION

There are more than 30 methods for measurement of HbA1c and these methods could be interfered by many factors. There are several studies about interferences on measurement of HbA1c with HPLC. In this case report, it has been shown that Hb H and HbA1c peaks are overlapped on the chromatogram and caused falsely high HbA1c level. Pravatmuang et al. reported that they found HbA1c levels were falsely low with the presence of Hb H (12). They thought that the possible explanation of these observations might be the amount of glycated β chain which polymerized as β4 or Hb H, and it was evaluated as the first peak of the non-quantitating area of the chromatogram which caused the HbA1c level by HPLC to be very low. Conversely, Lee at al. found HbA1c levels were falsely higher with the presence of Hb H (13). Lee at al. reported Hb H and HbA1c peaks were overlapped on the chromatogram and this caused falsely high HbA1c levels. However there are some methods for HbA1c assay which are not affected by hemoglobin variants (14), ion-exchange HPLC method which is widely used all over the world and in our laboratory, is prone to interference with these hemoglobin variants. In this case, we did not compare HbA1c assay methods. Patient’s HbA1c level was found 18.2% and it was assessed to be discordant with fasting plasma glucose level. Then hemoglobin electrophoresis was performed to evaluate this discordance. After electrophoresis, Hb H result was 10.8%. Because of the overlapping of HbA1c and Hb H peaks, the original HbA1c level was thought to be approximately 7.4%. However 7.4% value is compatible with fasting plasma glucose level, this value was not the exact value of course. In this regard, HbA1c levels could be measured with immunoturbidimetric method, so this kind of interferences could be overcome. As a result, HbA1c levels may falsely be found elevated, in the presence of Hb H, with ion-exchange HPLC. It is important to bear in mind not to confirm wrong results.
  11 in total

1.  Effect of hemoglobin variants (Hb J, Hb G, and Hb E) on HbA1c values as measured by cation-exchange HPLC (Diamat).

Authors:  L Y Tsai; S M Tsai; M N Lin; S F Liu
Journal:  Clin Chem       Date:  2001-04       Impact factor: 8.327

Review 2.  HbA1c: how do we measure it and what does it mean?

Authors:  Randie R Little; David B Sacks
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-04       Impact factor: 3.243

3.  Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods.

Authors:  Randie R Little; Curt L Rohlfing; Steve Hanson; Shawn Connolly; Trefor Higgins; Cas W Weykamp; Mario D'Costa; Veronica Luzzi; William E Owen; William L Roberts
Journal:  Clin Chem       Date:  2008-06-12       Impact factor: 8.327

4.  Effects of the Hb E, Hb H and Hb G-Taichung variants on HbA1c values by the Bio-Rad variant II turbo analyzer.

Authors:  Su-Chen Lee; Li-Hsuan Wang; Shih-Meng Tsai; Hung-Yao Fang; Li-Yu Tsai
Journal:  Clin Biochem       Date:  2011-08-17       Impact factor: 3.281

5.  Evaluation and interference study of hemoglobin A1c measured by turbidimetric inhibition immunoassay.

Authors:  J Chang; C Hoke; B Ettinger; G Penerian
Journal:  Am J Clin Pathol       Date:  1998-03       Impact factor: 2.493

6.  Evaluation of turbidimetric inhibition immunoassay (TINIA) and HPLC methods for glycated haemoglobin determination.

Authors:  Sema Genc; Beyhan Omer; Esra Aycan-Ustyol; Nurhan Ince; Fatih Bal; Figen Gurdol
Journal:  J Clin Lab Anal       Date:  2012-11       Impact factor: 2.352

7.  Effect of HbE and HbH on HbA1C level by ionic exchange HPLC comparing to immunoturbidimetry.

Authors:  P Pravatmuang; B Sae-Ngow; T Whanpuch; W Leowattana
Journal:  Clin Chim Acta       Date:  2001-11       Impact factor: 3.786

8.  Predicting clinical progression or death in subjects with early-stage human immunodeficiency virus (HIV) infection: a comparative analysis of quantification of HIV RNA, soluble tumor necrosis factor type II receptors, neopterin, and beta2-microglobulin. Multicenter AIDS Cohort Study.

Authors:  D S Stein; R H Lyles; N M Graham; C J Tassoni; J B Margolick; J P Phair; C Rinaldo; R Detels; A Saah; J Bilello
Journal:  J Infect Dis       Date:  1997-11       Impact factor: 5.226

9.  Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements.

Authors:  Nadzimah Mohd Nasir; M Thevarajah; Chew Yee Yean
Journal:  Int J Diabetes Dev Ctries       Date:  2010-04

10.  Automated determination of glycated hemoglobin: comparative evaluation of five assay systems.

Authors:  A Tiran; T Pieber; B Tiran; G Halwachs-Baumann; H Dobnig; H Grubelnig; M M Wilders-Truschnig
Journal:  J Clin Lab Anal       Date:  1994       Impact factor: 2.352

View more
  4 in total

Review 1.  HbA1C as a marker of retrograde glycaemic control in diabetes patient with co-existed beta-thalassaemia: A case report and a literature review.

Authors:  Zoran Gluvic; Milan Obradovic; Milena Lackovic; Vladimir Samardzic; Jelena Tica Jevtic; Magbubah Essack; Vladimir B Bajic; Esma R Isenovic
Journal:  J Clin Pharm Ther       Date:  2019-11-17       Impact factor: 2.512

2.  Led Astray by Hemoglobin A1c: A Case of Misdiagnosis of Diabetes by Falsely Elevated Hemoglobin A1c.

Authors:  Jean Chen; Amy Diesburg-Stanwood; Geza Bodor; Neda Rasouli
Journal:  J Investig Med High Impact Case Rep       Date:  2016-01-28

3.  Measurement of HbA1c and HbA2 by Capillarys 2 Flex Piercing HbA1c programme for simultaneous management of diabetes and screening for thalassemia.

Authors:  Peifeng Ke; Jiawei Liu; Yan Chao; Xiaobin Wu; Yujuan Xiong; Li Lin; Zemin Wan; Xinzhong Wu; Jianhua Xu; Junhua Zhuang; Xianzhang Huang
Journal:  Biochem Med (Zagreb)       Date:  2017-08-28       Impact factor: 2.313

4.  Haemoglobin A1C Levels Constantly Below Lower Reference Limit in a Diabetic Patient With Microcytic Anaemia.

Authors:  Frank S Fan; Chih-Hao Chen; Hui-Chun Yang
Journal:  Eur J Case Rep Intern Med       Date:  2019-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.